The Effect of Face Hand Fan Application on Dyspnea

COPD Clinical Trial

— HandfanCOPD  

Official title:

The Effect of Face Hand Fan Application on Dyspnea and Quality of Life in COPD Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06265831
• Other study ID #: BU-FHS-NC-03
• Status: Active, not recruiting
• Phase: N/A
• Start date: April 1, 2023
• Est. completion date: March 2024

Study information

• Verified date: February 2024
• Source: Bartin University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Diagnosing and managing dyspnea in patients with COPD is very important. Although pharmacological and non-pharmacological methods are used in the management of dyspnea, it is recommended that pharmacological methods be supported by non-pharmacological methods. Hand fan application, which is one of the non-pharmacological methods used in dyspnea management, provides an increase in self-efficacy in patients in addition to the stimulation of cold air flow to the trigeminal nerve branches, mucosa and skin. Although there are studies reporting that applying cold air to the face with a hand fan is effective in reducing the severity of dyspnea in different patient groups, the number of studies examining the effectiveness of applying cold air to the face with a hand fan in patients with COPD is quite limited. This project was planned to determine the effect of applying cold air to the face with a fan on the severity of dyspnea and quality of life in COPD patients.

Description:

Chronic obstructive pulmonary disease (COPD) is a chronic disease with a high incidence both in our country and around the world. Dyspnea is one of the common problems in COPD patients. Dyspnea is an important symptom that limits patients' physical mobility, causes psychological problems such as anxiety, depression, and panic, and negatively affects their quality of life. Therefore, it is very important to diagnose and manage dyspnea in patients with COPD. Although pharmacological and non-pharmacological methods are used in the management of dyspnea, it is recommended that pharmacological methods be supported by non-pharmacological methods. Hand fan application, which is one of the non-pharmacological methods used in dyspnea management, provides an increase in self-efficacy in patients in addition to the stimulation of cold airflow to the trigeminal nerve branches, mucosa, and skin. Although there are studies reporting that applying cold air to the face with a hand fan is effective in reducing the severity of dyspnea in different patient groups, the number of studies examining the effectiveness of applying cold air to the face with a hand fan in patients with COPD is quite limited. This project was planned to determine the effect of applying cold air to the face with a fan on the severity of dyspnea and quality of life in COPD patients. Method: The research was planned as a randomized, controlled experimental design. The population of the research consists of patients treated with a diagnosis of COPD in Bartın State Hospital Chest Diseases Service. Considering the data obtained from a similar study, the sample was calculated as 64 patients in the intervention group and 64 patients in the control group, for a total of 128 patients. Data will be collected using the Descriptive Information Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire. Data will be collected by researchers through face-to-face interviews with COPD patients treated at Bartın State Hospital Chest Diseases Service. Patients receiving treatment with a diagnosis of COPD will be randomized into intervention and control groups. In the control group, the Patient Diagnosis Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled in at the first interview. The clinic's routine care protocol will be applied to the patients in the control group, and the researchers will fill out a vital signs form every day for 7 days, and the patients will be followed up. At the first meeting of the intervention group, the Patient Identification Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled out. Afterward, training will be given (accompanied by an academic advisor) on how to apply cold air to the face with a hand fan (3 times a day for 5 minutes) for dyspnea management. Additionally, patients will be given a hand-fan application brochure. The researchers will monitor the patient every day for a week (7 days), fill out the vital signs form, and the final test will be administered by the researchers on the 8th day.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 61
• Est. completion date: March 2024
• Est. primary completion date: November 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Having been diagnosed with COPD at least 6 months ago,
• Being over 18 years of age,
• No open wounds on the face for any reason,
• Lung cancer, tuberculosis, asthma etc. absence of other respiratory system diseases,
• Not having a hearing or speech impairment,
• Not having a cognitive disability
• Volunteering to participate in the research.

Exclusion Criteria:

• Being diagnosed with COPD less than 6 months ago,
• Being under 18 years of age,
• Having an open wound on the face for any reason,
• Lung cancer, tuberculosis, asthma etc. Having other respiratory system diseases,
• Having hearing and speech impairment,
• Having a cognitive disability
• Not volunteering to participate in the research.

Related Conditions & MeSH terms

• COPD
• Dyspnea

Intervention

Other:
• Hand-fan application to the face
Hand fan application is one of the applications recommended in managing dyspnea in evidence-based guidelines. Hand fan application effectively reduces shortness of breath by stimulating cold airflow to the 2nd and 3rd trigeminal nerve branches, mucosa, and skin.

Locations

Country	Name	City	State
Turkey	Necmiye ÇÖMLEKÇI	Bartin

Sponsors (2)

Lead Sponsor	Collaborator
Bartin University	The Scientific and Technological Research Council of Turkey

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modified Borg Scale	The Modified Borg Scale was first developed by Gunnar Borg in 1970 to measure the effort expended during physical exercise. Later, MBS was revised in 1982 and became a scale consisting of 12 items that diagnose the severity of dyspnea according to its degree. As the points on the scale increase, the severity of dyspnea increases (0: None, 0.5: Very very mild, 1: Very mild, 2: Mild, 3: Moderate, 4: Somewhat severe, 5: Severe, 6: 7: Very severe, 8: ….., 9: Very very serious, 10: Maximum). Although MBS was first used to define the severity of exertional dyspnea, it is now also used to evaluate the severity of resting dyspnea.	a week (seven days)
Secondary	Saint George Respiratory Questionnaire	Saint George Respiratory Questionnaire is a survey created by Jones in 2009 to evaluate the health-related quality of life of patients diagnosed with COPD. The survey consists of 50 items and 3 main sections. These sections; symptoms (8 items), activity (16 items) and effects of the disease (26 items). The questionnaire evaluates respiratory symptoms, activities restricted due to dyspnea, and the impact of this condition on daily life. In the evaluation, the total score of the survey is distributed between 0 and 100. A score of 0 indicates that there is no deterioration in the quality of life, while a score of 100 indicates that the quality of life is increasingly negatively affected. In the reliability analysis of SGSA, Cronbach's alpha coefficient was found to be 0.88 for the entire scale.	a week (seven days)